Azenta, Inc. (NASDAQ:AZTA) Shares Bought by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC raised its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 11.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 320,137 shares of the company's stock after acquiring an additional 32,037 shares during the period. Segall Bryant & Hamill LLC owned approximately 0.70% of Azenta worth $11,090,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the business. KLP Kapitalforvaltning AS purchased a new stake in shares of Azenta during the fourth quarter worth $530,000. Deutsche Bank AG boosted its stake in Azenta by 28.5% during the fourth quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock worth $210,000 after buying an additional 931 shares during the period. Thrivent Financial for Lutherans boosted its stake in Azenta by 206.5% during the fourth quarter. Thrivent Financial for Lutherans now owns 35,223 shares of the company's stock worth $1,761,000 after buying an additional 23,731 shares during the period. SG Americas Securities LLC boosted its stake in Azenta by 90.6% during the first quarter. SG Americas Securities LLC now owns 30,972 shares of the company's stock worth $1,073,000 after buying an additional 14,719 shares during the period. Finally, Corient Private Wealth LLC boosted its stake in shares of Azenta by 12.7% in the fourth quarter. Corient Private Wealth LLC now owns 28,505 shares of the company's stock valued at $1,425,000 after purchasing an additional 3,221 shares during the period. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Azenta Stock Down 3.0%

NASDAQ:AZTA traded down $0.95 during midday trading on Friday, reaching $31.16. The stock had a trading volume of 637,774 shares, compared to its average volume of 740,826. The firm has a fifty day simple moving average of $29.75 and a two-hundred day simple moving average of $36.53. Azenta, Inc. has a 12-month low of $23.91 and a 12-month high of $63.58. The stock has a market cap of $1.43 billion, a P/E ratio of -22.42 and a beta of 1.64.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a positive return on equity of 1.30% and a negative net margin of 10.31%. The business's revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.06 EPS. On average, sell-side analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

AZTA has been the topic of several analyst reports. Needham & Company LLC reduced their target price on shares of Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a report on Wednesday, May 7th. Evercore ISI raised their target price on shares of Azenta from $29.00 to $35.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.